Clonidine is NOT an effective treatment for essential tremor and should not be used for this indication
For a patient with essential tremor who cannot tolerate beta-blockers due to asthma, clonidine is not a suitable alternative. The evidence clearly demonstrates that clonidine lacks efficacy for essential tremor, despite some early optimistic reports 1, 2.
Evidence Against Clonidine for Essential Tremor
The highest quality controlled trial directly addressing this question found clonidine ineffective for essential tremor 3. In a double-blind, placebo-controlled study using objective accelerometric measurements, clonidine (average dose 0.4 mg/day) produced no significant reduction in tremor amplitude or frequency, while causing frequent side effects 3.
While one older Spanish trial 4 suggested clonidine might have some benefit, this study had significant methodological limitations and notably reported significantly higher dropout rates in the clonidine group (22 patients, p=0.006) due to side effects, particularly dry mouth. Even in this more favorable study, propranolol was not shown to be inferior to clonidine, but the high discontinuation rate undermines any claim of clinical utility 4.
Recommended Alternatives for This Patient
Primidone should be the first-line alternative for patients with essential tremor who cannot use beta-blockers 2, 5. Primidone and propranolol are effective in up to 70% of patients with essential tremor 2.
Treatment Algorithm:
First-line (when beta-blockers contraindicated): Primidone
- Start low (25-50 mg at bedtime) and titrate slowly to minimize sedation
- Effective doses typically 250-750 mg/day divided
Second-line options (if primidone fails or not tolerated):
For refractory cases:
Why Beta-Blockers Are Contraindicated in This Patient
Non-selective beta-blockers (like propranolol) are absolutely contraindicated in asthma 6, 7, 8, 9. They cause bronchoconstriction and can precipitate severe, potentially fatal asthma exacerbations 9.
Even cardioselective beta-blockers carry risk in asthma patients. While metoprolol (cardioselective) may be used cautiously when strongly indicated and no alternatives exist, the 2017 ACC/AHA guidelines explicitly state to "avoid in patients with reactive airways disease" for non-cardioselective agents 6, 7. For essential tremor specifically, this risk-benefit calculation does not favor beta-blocker use when effective alternatives exist 9.
Addressing the Anxiety Component
If anxiety is a significant comorbidity requiring separate treatment, clonidine may have some role for anxiety based on emerging evidence 10, but this is distinct from treating the tremor itself. The anxiety indication would need to be weighed against clonidine's side effect profile (sedation, hypotension, bradycardia, rebound hypertension with abrupt discontinuation) 6, 7, 11.
Critical Safety Warnings for Clonidine:
- Never discontinue abruptly - can cause hypertensive crisis with rebound hypertension 6, 7, 11
- Must taper over 2-4 days when stopping 11
- Reserved as last-line antihypertensive due to significant CNS adverse effects, especially in older adults 6, 7
- Common side effects: somnolence, fatigue, dry mouth, sedation, bradycardia 12
Bottom Line
Do not use clonidine for essential tremor. Start primidone as first-line therapy in this patient who cannot tolerate beta-blockers due to asthma. If tremor remains refractory after optimizing primidone and trying second-line medications, refer for specialized interventions including botulinum toxin or surgical options.